Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000-2012).
Ambrosioni J, Hernández-Meneses M, Durante-Mangoni E, Tattevin P, Olaison L, Freiberger T, Hurley J, Hannan MM, Chu V, Hoen B, Moreno A, Cuervo G, Llopis J, Miró JM; International Collaboration for Endocarditis (ICE) Investigators. Ambrosioni J, et al. Infect Dis Ther. 2023 Apr;12(4):1083-1101. doi: 10.1007/s40121-023-00763-8. Epub 2023 Mar 15. Infect Dis Ther. 2023. PMID: 36922460 Free PMC article.
Correction: Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000-2012).
Ambrosioni J, Hernández-Meneses M, Durante-Mangoni E, Tattevin P, Olaison L, Freiberger T, Hurley J, Hannan MM, Chu V, Hoen B, Moreno A, Cuervo G, Llopis J, Miró JM; International Collaboration for Endocarditis (ICE) Investigators. Ambrosioni J, et al. Infect Dis Ther. 2023 Dec;12(12):2819-2821. doi: 10.1007/s40121-023-00898-8. Infect Dis Ther. 2023. PMID: 38100016 Free PMC article. No abstract available.
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in Greece and Italy-SMART 2017-2021.
Karlowsky JA, Lob SH, Hawser SP, Kothari N, Siddiqui F, Alekseeva I, DeRyke CA, Young K, Motyl MR, Sahm DF. Karlowsky JA, et al. Eur J Clin Microbiol Infect Dis. 2024 May 22. doi: 10.1007/s10096-024-04756-4. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38775873
Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018-2022.
Wise MG, Karlowsky JA, Mohamed N, Hermsen ED, Kamat S, Townsend A, Brink A, Soriano A, Paterson DL, Moore LSP, Sahm DF. Wise MG, et al. Among authors: karlowsky ja. J Glob Antimicrob Resist. 2024 Apr 10;37:168-175. doi: 10.1016/j.jgar.2024.03.020. Online ahead of print. J Glob Antimicrob Resist. 2024. PMID: 38608936 Free article.
Moving towards a standardized definition of antimicrobial resistance: a comparison of the antimicrobial susceptibility profile of difficult-to-treat resistance (DTR) versus multidrug-resistant (MDR) Pseudomonas aeruginosa clinical isolates (CANWARD, 2016-2021).
Walkty A, Karlowsky JA, Lagacé-Wiens PRS, Baxter MR, Adam HJ, Bay DC, Zhanel GG. Walkty A, et al. Among authors: karlowsky ja. Diagn Microbiol Infect Dis. 2024 Feb;108(2):116130. doi: 10.1016/j.diagmicrobio.2023.116130. Epub 2023 Nov 17. Diagn Microbiol Infect Dis. 2024. PMID: 38006710
358 results